ERBB2 and breast carcinoma: Among these, basal-like breast cancers (BLBCs) are mostly ERα, PR, and HER2 triple-negative breast cancers (TNBCs), which comprise 15-20% of all breast cancer diagnoses and are associated with poor prognosis, high risk of distant recurrence, and low five-year survival 3.